New Speaker Interview released with Geraint Davies, for Wearable Injectors & Connected Devices Conference

SAE Media Group's 3rd annual Wearable Injectors and Connected Devices Conference, taking place on the 10th and 11th of October 2022, in London, UK, will explore on-body device design and development whilst also engaging in the latest advances in connectivity and digital health applications for wearable devices with industry perspectives from big pharma representatives.

Interested parties can register for the conference at: http://www.wearable-injectors.co.uk/PR3OR
and SAVE £200 by 31st August!

Ahead of the Wearable Injectors & Connected Devices Conference, SAE Media Group caught up with Geraint Davies, Principal Human Factors Engineer, at Roche to talk about the challenges, upcoming projects and developments within the Wearable Injectors and Connected Devices industry.

The Wearable Injectors and Connected Devices market has grown rapidly over the past few years, what key difference have you noticed in the last year regarding significant developments?
Industry is starting to realise and plan for the complexities outside of the connectivity technology. The ability to connect injection devices to mobile phones is kind of the easy part of the solution. Building something that patients, caregivers and HCPs want to use consistently requires a whole different skill set. In addition, other factors such as creating a digital strategy around how we use the data, software development processes, system architecture, data management and cybersecurity are relatively new to the medical device sector and have been the areas of steepest learning.

We are seeing a digital revolution throughout pharma and for injectable delivery which comes in the form of connected devices. What would you say the main drivers are for this?
The reasons are multifaceted; in general, we are seeing the digitisation of every aspect of our lives, so it is an obvious progression for the healthcare sector and the expectations and capabilities of our users are advancing as well. There has also been a drive towards self-administration / at home care monitoring (exacerbated by Covid).

What do you see as the greatest challenge for you to overcome personally in the Wearable Injectors and Connected Devices field?
Creating solutions that are genuinely valuable to patients and HCP's, that have been designed to accommodate the way humans actually behave and make decisions.

To read the full speaker interview and view the programme please visit: http://www.wearable-injectors.co.uk/PR3OR

For sponsorship enquiries please contact Andrew Gibbons on +44 (0)20 7827 6156 or email at agibbons@smi-online.co.uk

For media enquiries or a press pass contact Marketing, Nikisha Galoria on +44 (0) 20 7827 6154 or email ngaloria@smi-online.co.uk

3rd Annual Wearable Injectors and Connected Devices Conference
10 - 11 October 2022
London, UK
Sponsors & Exhibitors: DCA, Quantex, Victrex, DMI, Raumedic, Sensirion, Mikron
http://www.wearable-injectors.co.uk/PR3OR

India House, 45 Curlew Street

--------- END---------

About SAE Media Group Conferences:
SAE Media Group Conferences connects global communities with focused networking conferences. We provide our customers with solutions through industry knowledge and collaboration that enables our attendees to return to their organisations better equipped to overcome their key business challenges. Our key events focus on Defence and Aerospace, Pharmaceutical and Medical. Each year we bring together over 5,000 senior business professionals at our conferences. http://www.smgconferences.com
SAE Media Group (SMG), a subsidiary of SAE International, reports the latest technology breakthroughs and design innovations to a global audience of nearly 1,000,000 engineers, researchers, and business managers. SMG provides critical information these professionals need to develop new and improved products and services.

This release was published on openPR.